26959819|t|Plasmalogen Augmentation Reverses Striatal Dopamine Loss in MPTP Mice.
26959819|a|Plasmalogens are a class of glycerophospholipids shown to play critical roles in membrane structure and function. Decreased plasmalogens are reported in the brain and blood of Parkinson's disease (PD) patients. The present study investigated the hypothesis that augmenting plasmalogens could protect striatal dopamine neurons that degenerate in response to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treatment in mice, a PD model. First, in a pre-treatment experiment male mice were treated for 10 days with the docosahexaenoic acid (DHA)-plasmalogen precursor PPI-1011 (10, 50 and 200 mg/kg). On day 5 mice received MPTP and were killed on day 11. Next, in a post-treatment study, male mice were treated with MPTP and then received daily for 5 days PPI-1011 (5, 10 and 50 mg/kg). MPTP treatment reduced serum plasmalogen levels, striatal contents of dopamine (DA) and its metabolites, serotonin, DA transporter (DAT) and vesicular monoamine transporter 2 (VMAT2). Pre-treatment with PPI-1011 (10 and 50 mg/kg) prevented all MPTP-induced effects. Positive correlations were measured between striatal DA contents and serum plasmalogen levels as well as striatal DAT and VMAT2 specific binding. Post-treatment with PPI-1011 prevented all MPTP-induced effects at 50 mg/kg but not at lower doses. Positive correlations were measured between striatal DA contents and serum plasmalogen levels as well as striatal DAT and VMAT2 specific binding in the post-treatment experiment. PPI-1011 treatment (10 days at 5, 10 and 50 mg/kg) of intact mice left unchanged striatal biogenic amine contents. These data demonstrate that treatment with a plasmalogen precursor is capable of protecting striatal dopamine markers in an animal model of PD. 
26959819	0	11	Plasmalogen	Chemical	MESH:D010955
26959819	43	51	Dopamine	Chemical	MESH:D004298
26959819	60	64	MPTP	Chemical	MESH:D015632
26959819	65	69	Mice	Species	10090
26959819	99	119	glycerophospholipids	Chemical	MESH:D020404
26959819	247	266	Parkinson's disease	Disease	MESH:D010300
26959819	268	270	PD	Disease	MESH:D010300
26959819	272	280	patients	Species	9606
26959819	380	388	dopamine	Chemical	MESH:D004298
26959819	428	472	1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	Chemical	MESH:D015632
26959819	474	478	MPTP	Chemical	MESH:D015632
26959819	493	497	mice	Species	10090
26959819	501	503	PD	Disease	MESH:D010300
26959819	553	557	mice	Species	10090
26959819	592	612	docosahexaenoic acid	Chemical	MESH:D004281
26959819	614	617	DHA	Chemical	MESH:D004281
26959819	619	630	plasmalogen	Chemical	MESH:D010955
26959819	641	649	PPI-1011	Chemical	MESH:C000711075
26959819	683	687	mice	Species	10090
26959819	697	701	MPTP	Chemical	MESH:D015632
26959819	767	771	mice	Species	10090
26959819	790	794	MPTP	Chemical	MESH:D015632
26959819	830	838	PPI-1011	Chemical	MESH:C000711075
26959819	861	865	MPTP	Chemical	MESH:D015632
26959819	890	901	plasmalogen	Chemical	MESH:D010955
26959819	931	939	dopamine	Chemical	MESH:D004298
26959819	941	943	DA	Chemical	MESH:D004298
26959819	966	975	serotonin	Chemical	MESH:D012701
26959819	977	991	DA transporter	Gene	13162
26959819	993	996	DAT	Gene	13162
26959819	1002	1035	vesicular monoamine transporter 2	Gene	214084
26959819	1037	1042	VMAT2	Gene	214084
26959819	1064	1072	PPI-1011	Chemical	MESH:C000711075
26959819	1105	1109	MPTP	Chemical	MESH:D015632
26959819	1180	1182	DA	Chemical	MESH:D004298
26959819	1202	1213	plasmalogen	Chemical	MESH:D010955
26959819	1241	1244	DAT	Gene	13162
26959819	1249	1254	VMAT2	Gene	214084
26959819	1293	1301	PPI-1011	Chemical	MESH:C000711075
26959819	1316	1320	MPTP	Chemical	MESH:D015632
26959819	1426	1428	DA	Chemical	MESH:D004298
26959819	1448	1459	plasmalogen	Chemical	MESH:D010955
26959819	1487	1490	DAT	Gene	13162
26959819	1495	1500	VMAT2	Gene	214084
26959819	1552	1560	PPI-1011	Chemical	MESH:C000711075
26959819	1613	1617	mice	Species	10090
26959819	1651	1656	amine	Chemical	MESH:D000588
26959819	1712	1723	plasmalogen	Chemical	MESH:D010955
26959819	1768	1776	dopamine	Chemical	MESH:D004298
26959819	1807	1809	PD	Disease	MESH:D010300
26959819	Negative_Correlation	MESH:D010955	MESH:D015632
26959819	Positive_Correlation	MESH:C000711075	MESH:D004281
26959819	Negative_Correlation	MESH:C000711075	MESH:D015632
26959819	Positive_Correlation	MESH:D004298	MESH:D010955
26959819	Association	MESH:D004298	214084
26959819	Negative_Correlation	MESH:D004298	MESH:D015632
26959819	Negative_Correlation	MESH:D015632	13162
26959819	Negative_Correlation	MESH:D015632	214084
26959819	Negative_Correlation	MESH:D012701	MESH:D015632
26959819	Association	MESH:C000711075	MESH:D010955

